UBS Group AG

Position in PLRX — Pliant Therapeutics, Inc.

CIK 1610520 ZURICH, V8

Position in PLRX

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$1,333,022

+$36,632 QoQ

Shares Held

1,057,954

-0.4% QoQ

Ownership

1.71%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

23 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. PLRX ranks #235 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	22,619,472	$626,559,372
2	PTGX	Protagonist Therapeutics, Inc	5,177,796	$545,739,697
3	ABVX	Abivax S.A.	4,547,406	$506,353,656
4	RVMD	Revolution Medicines, Inc.	4,386,791	$426,615,424
5	INSM	INSMED Inc	1,737,481	$284,112,890
6	VRTX	Vertex Pharmaceuticals Inc / Ma	630,618	$281,596,158
7	APLS	Apellis Pharmaceuticals, Inc.	6,206,681	$249,694,775
8	REGN	Regeneron Pharmaceuticals, Inc.	299,979	$231,775,770

23 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,333,022	1,057,954	-0.4%	Shares	Defined	2026-05-05
2025-12-31	$1,296,390	1,062,615	-19.6%	Shares	Defined	2026-01-29
2025-09-30	$1,956,584	1,322,017	-50.0%	Shares	Defined	2025-11-13
2025-06-30	$3,070,004	2,646,556	+0.0%	Shares	Defined	2025-08-14
2025-03-31	$3,571,486	2,645,546	+321.1%	Shares	Defined	2025-05-13
2024-12-31	$8,274,460	628,281	+172.8%	Shares	Defined	2025-02-14
2024-09-30	$2,581,752	230,308	+51.3%	Shares	Sole	2024-11-14
2024-06-30	$1,636,171	152,202	-58.3%	Shares	Defined	2024-08-14
2024-03-31	$5,439,453	365,064	+6.7%	Shares	Defined	2024-05-13
2023-12-31	$6,196,753	342,173	+26.4%	Shares	Defined	2024-02-09
2023-09-30	$4,695,741	270,804	+8855.2%	Shares	Defined	2023-11-09
2023-06-30	$54,793	3,024	-79.2%	Shares	Defined	2023-08-11
2023-03-31	$387,295	14,560	+169.9%	Shares	Defined	2023-05-12
2022-12-31	$104,284	5,395	-18.3%	Shares	Defined	2023-02-08
2022-09-30	$137,873	6,600	+86.6%	Shares	Defined	2022-11-10
2022-06-30	$28,330	3,537	+18.4%	Shares	Defined	2022-08-10
2022-03-31	$20,938	2,987	-71.1%	Shares	Defined	2022-05-16
2021-12-31	$139,333	10,321	+434.8%	Shares	Defined	2022-02-14
2021-09-30	$32,577	1,930	+38.2%	Shares	Defined	2021-11-15
2021-06-30	$40,680	1,397	+55.9%	Shares	Sole	2021-08-13
2021-03-31	$35,239	896	-35.0%	Shares	Sole	2021-05-12
2020-12-31	$31,330	1,379	-45.1%	Shares	Defined	2021-02-11
2020-09-30	$56,851	2,510	—	Shares	Defined	2020-11-12
No filing history on record for this holder in this stock.